The results revealed that the group with high TXNL4A expression exhibited increased docetaxel tolerance, embryonic stem cells, ROBO receptor signaling pathway dysregulation, tumor invasion, undifferentiated carcinoma, DNA damage, replication, and dysregulation of other pathways (Figures 5A–F). The gene discussed is TXNL4A; the disease is neoplasm.